Maxime Ronot retweeted
Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy | Targeted and Immune Therapy | JAMA Oncology | JAMA Network jamanetwork.com/journals/jam…
🚨EASL CPG on the management of HCC in @JHepatology
Major update!
✅ LI-RADS endorsed
✅ Refined treatment algo
✅ More evidence supporting locoregional treatments
✅ Up-to-date discussions
👉bit.ly/3VKZmcy
Maxime Ronot retweeted
🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️
✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data
Full text👉bit.ly/3VKZmcy
#CPGs
#LiverTwitter
@EASLnews
@EASLedu
@AleksanderKrag
Maxime Ronot retweeted
🔥off the press: Tumor burden with AFP improves survival prediction for TACE treated patients with HCC
@JHEP_Reports
doi.org/10.1016/j.jhepr.2024…
🔎 International observational study
👉Easy to use tool to predict outcome
@myESMO @EASLedu @ILCAnews
Maxime Ronot retweeted
❕Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
🔓#OpenAccess at👉jhep-reports.eu/article/S258…
#LiverTwitter
#HCC
@NaultJc
Maxime Ronot retweeted
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment - The Lancet Oncology thelancet.com/journals/lanon…
Maxime Ronot retweeted
🩺MRI-assessed intratumoral fat was generally nonprognostic; however, homogeneous intratumoral fat correlated with longer recurrence-free and overall survival in an Asian cohort of hepatocellular carcinoma patients. Findings from @maximeronot!
pubs.rsna.org/doi/10.1148/ra…
Maxime Ronot retweeted
Risk of HCC in Subcentimeter Liver Nodules Identified on Surveillance Ultrasound
@AGA_CGH
doi.org/10.1016/j.cgh.2024.0…
🔎 Systematic Review, 9 studies, 888 pts
👉risk of HCC: 21.3%
👉risk factors: older age, male sex, elevated AFP, low plts, CP B
🧐repeat ultrasound in 3-6 mo reasonable
@myESMO @EASLnews @ILCAnews #livertwitter
Maxime Ronot retweeted
Read 'open access' at bit.ly/3AdVol6
"Early-Life Infections, Antibiotics and Later Risk of Childhood and Early Adult-Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts" by Mårild et al
#GItwitter #IBD

ALT This Scandinavian binational cohort study found that early-life antibiotic use was associated with IBD development in childhood or young adulthood, independent of early-life infection frequency. Infection frequency itself was not a major risk factor. Our findings suggest that antibiotics, rather than infection frequency, may influence IBD risk.
Maxime Ronot retweeted
💥EXPERT OPINION
Integration of new technologies in the multidisciplinary approach to primary liver tumours
➡️The next-generation tumour board
Full text here👉journal-of-hepatology.eu/art…
@Naultjc
#LiverTwitter
Maxime Ronot retweeted
🔥off the press
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC
@JHEP_Reports
🔎🗺️RWD study
❓how to best select for TACE > AFP & Tumor burden
🧐helpful for the discussion in the tumor board
👇my author link:
doi.org/10.1016/j.jhepr.2024…
@myESMO @EASLedu @ILCAnews #livertwitter
Maxime Ronot retweeted
The position paper from EASL about "management of rare primary liver cancers" was recently published in Journal Of Hepatology @EASLnews @JHepatology @campani_claudia @Zucmanrossi @ma5RN journal-of-hepatology.eu/art…
Maxime Ronot retweeted
Updated data for atezo + bev vs surveillance in resected or ablated high risk HCC
#ESMO24
🔎IMbrave050
👉RFS 33.2 vs 36 mo, HR 0.9
👉OS: HR: 1.26
🧐Benefit not sustained! Disappointing..
🧐Caveat of (too) early read outs…
@myESMO #ESMOAmbassadors @ILCA @EASLedu
Maxime Ronot retweeted
Congratulations to @F_matteini and team @marco_dioguardi @maximeronot @DrF_Vernuccio for the article "Discontinuous peripheral enhancement of focal liver lesions on CT and MRI: outside the box of typical cavernous hemangioma" published in @Abdominal_Rad
🔗doi.org/10.1007/s00261-024-0…
Maxime Ronot retweeted
🚨 A new episode of the @radiology_rsna podcast is now available! 🚨 @LindaChuMD speaks with Dr. Lorenzo Garzelli and @maximeronot about Predictors of Intestinal Resection–Free Survival after Endovascular Revascularization #RadPodcasts bit.ly/4f9mrh2
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
Amazing collective work 💪
Everything there is to know, and more!
+ a new set of imaging criteria to play with ⬇️
thelancet.com/journals/langa… @ValdigGroup
@RautouE
Maxime Ronot retweeted
📢The "VALDIG PVT criteria" we propose here will help homogenize studies on portal vein thrombosis in patients without and with cirrhosis
✅agreement > 90 % among 57 international experts‼️
Maxime Ronot retweeted
New Review - Elkrief et al - Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
thelancet.com/journals/langa… @ERN_RARE_LIVER @ValdigGroup #LiverTwitter @RautouE
Maxime Ronot retweeted
1/2
Cholangiocarcinoma is a rare but serious liver cancer😕
🇫🇷 French experts have created guidelines to help doctors diagnose and treat it
🔬 Covers risk factors, screening, diagnosis, and treatment options
🔓 bit.ly/3S6mCzQ
#livertwitter































